期刊文献+

女性腹膜原发癌11例临床病理及免疫组化特征 被引量:2

Primary peritoneal carcinomas of females: Clinicopathologic analysis and immunohistochemical study of 11 cases
下载PDF
导出
摘要 目的 :探讨女性腹膜原发癌的临床病理学特征。方法 :复习 11例腹膜原发癌病例 ,分析其临床及病理学特征 ,并进行免疫组化染色研究。结果 :病人除 1例外均为绝经后妇女 ,以腹胀为主要临床表现。 10例病人出现腹水且细胞学检查找到癌细胞。组织学检查 :6例为浆液性乳头状腺癌 ,4例为低分化浆液性腺癌部分区域伴有鳞状细胞癌或移行细胞癌成分 ,1例为移行细胞癌。免疫组化染色 :所有病例的肿瘤组织对CK7及EMA均呈明确的阳性表达 ;其中 8例肿瘤对S 10 0蛋白有不同程度的阳性表达 ;部分病例对CEA、Calretinin及Vimentin呈局灶弱阳性表达 ;没有病例显示CK2 0阳性。结论 :女性腹膜原发癌是起源于第二M櫣llerian系统的肿瘤 ,好发于绝经后妇女 ,与卵巢肿瘤相似 ,腹膜原发癌也可显示多种组织类型。免疫组化染色有助于区别胃肠道转移癌及间皮瘤。 Objective: To observe and analyze the clinicopathological features of primary peritoneal carcinoma in women. Methods: Eleven cases of primary peritoneal carcinoma in female patients were reviewed. The clinical and pathological records as well as all the available cytological and histological slides were reviewed. Immunohistochemical studies were performed in formalin fixed paraffin embedded tissue blocks of the peritoneal tumors. Results: The patients were postmenopausal females except one case. All the patients presented with abdominal distension. They were found to have ascites with positive cytology documented in ten cases. Laparotomy revealed multiple neoplastic nodules at the omentum and other peritoneal surfaces. Histologically, six were serous papillary adenocarcinoma, one was transitional cell carcinoma, and four were poorly differentiated serous adenocarcinoma with squamous cell carcinoma and/or transitional cell carcinoma components. Immunoreactivity for CK7 and EMA were demonstrated in all tumor tissues, 73% (8/11) of the tumors were positive for S 100 protein, while a few cases showed weak positivity for CEA, Calretinin and Vimentin. None of the cases were immunoreactive for CK 20. Conclusion: Primary peritoneal carcinomas of females are considered to arise from the secondary Müllerian system. They occur predominantly in postmenopausal women. The carcinomas may also display a wide variety of morphological appearances comparable to their ovarian counterparts. Immunohistochemical studies may be useful in distinguishing these tumors from metastasis from gastrointestinal tract and mesothelioma.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2001年第5期435-437,共3页 Journal of Peking University:Health Sciences
关键词 腹膜肿瘤 病理学 第二Muellerian系统 免疫组织化学 原发癌 女性 Peritoneal neoplasms/pathol Secondary Müllerian system Histochemistry
  • 相关文献

参考文献5

二级参考文献6

  • 1廖松林.腹膜的肿瘤及肿瘤样病变.现代诊断病理学年鉴[M].香港中文大学病理解剖及细胞学系,1997.73-87.
  • 2廖松林,现代诊断病理学年鉴,1997年,73页
  • 3Zhou J,Cancer,1995年,76卷,429页
  • 4Wauters C C,Hum Pathology,1995年,26卷,852页
  • 5Moll R,Am J Pathol,1992年,140卷,427页
  • 6Young R H,Int J Gynecol Pathol,1992年,11卷,96页

共引文献32

同被引文献24

  • 1余健,张国楠,樊英,田昌英,谢芳.原发性腹膜癌10例临床及病理分析[J].华西医学,2005,20(3):479-480. 被引量:3
  • 2卞度宏 叶之美 等.原发性腹膜乳头状浆液性腺癌6例报告[J].中华妇产科杂志,1988,23(6):379-380.
  • 3Fromm GL, Gershenson DM, Silva EG. Papillary serous carcinoma of the peritoneum. Obstet Gynecol, 1990,75:89-95.
  • 4Bloss JD, Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol,1993,50:347-351.
  • 5Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report.Am J Obstet Gynecol,1959,77:197-200.
  • 6Eltabbakh GH, Piver MS, Natarajan N, et al. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol,1998,91:254-259.
  • 7Bloss JD, Brady MF, Liao SY, et al. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study. Gynecol Oncol,2003,89:148-154.
  • 8Piver MS, Jishi MF, Tsukada Y, et al. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer,1993,71: 2751-2755.
  • 9Piver MS, Eltabbakh GH, Hempling RE, et al. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol Oncol, 1997,67:141-146.
  • 10Altaras MM, Aviram R, Cohen I, et al. Primary peritoneal papillary serous adenocarcinoma: clinical and management aspects. Gynecol Oncol,1991,40:230-236.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部